Skip to search formSkip to main contentSkip to account menu

therapeutic autologous dendritic cells

Known as: ADC, autologous dendritic cells 
A population of a type of antigen-presenting cell (APC), the dendritic cell (DC), harvested from a patient and grown in vitro in the presence of… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Purpose of reviewWe discuss the use of tolerogenic dendritic cells (TolDCs) as a therapeutic tool in solid organ transplantation… 
Review
2011
Review
2011
tation market (Table 1). In the cell-therapy arena, the main competitor is Cytori Therapeutics of San Diego, which markets a… 
2009
2009
Abstract:  Immature DCs were generated from the peripheral blood monocytes from five children with refractory solid tumors (Ewing… 
2005
2005
Purpose: To determine the toxicity, maximal tolerated dose, and clinical and immunologic response to autologous dendritic cells… 
2002
2002
Objective To utilize the potent antigen-presenting capacity of mature dendritic cells (MDC) in order to develop a rapid… 
2001
2001
Human papillomavirus (HPV) infection represents the most important risk factor for developing cervical cancer. In this study, we… 
Highly Cited
2000
Highly Cited
2000
Immunoglobulin secreted by myeloma cells contains a unique antigenic determinant (idiotype [Id]) that may serve as a tumor… 
2000
2000
A mouse HER2‐derived peptide, HER2p63 (A) (TYLPANASL), can induce Kd‐restricted mouse cytotoxic T lymphocytes (CTL) and also… 
Highly Cited
1999
Highly Cited
1999
Dendritic cells (DC), generated from adherent peripheral blood mononuclear cells (PBMC) by culturing with granulocyte‐macrophage… 
1987
1987
The stage of activation of synovial inflammatory T cells was studied in rheumatoid arthritis and compared with that of normal T…